Follow-Up Study Confirms the Presence of Gastric Cancer DNA Methylation Hallmarks in High-Risk Precursor Lesions
暂无分享,去创建一个
J. Gisbert | M. Esteller | C. González | J. Sanz-Anquela | M. Berdasco | S. Lario | M. J. Ramírez-Lázaro | M. Cuatrecasas | Miguel L. Pato | L. Bujanda | J. Barrio | N. Sala | A. Gómez | M. Martín-Arranz | Á. Ferrández | O. Companioni | M. Tufano | Consuelo López | V. Andreu | Á. Cosme | José-Ignacio Elizalde | M. Paúles | L. Ortega | E. Poves | G. Muñoz | M. Á. Torres | David J. Hanly | Nadia García | María Ángeles Torres | Miguel L Pato
[1] P. Kemmeren,et al. DNA Methylation Profiling Identifies Distinct Clusters in Angiosarcomas , 2019, Clinical Cancer Research.
[2] R. Tabrizi,et al. Gastric cancer in patients with gastric atrophy and intestinal metaplasia: A systematic review and meta-analysis , 2019, PloS one.
[3] Walter G. Park,et al. Novel Methylated DNA Markers Discriminate Advanced Neoplasia in Pancreatic Cysts: Marker Discovery, Tissue Validation, and Cyst Fluid Testing. , 2019, The American journal of gastroenterology.
[4] Judy H. Cho,et al. Blood-Derived DNA Methylation Signatures of Crohn's Disease and Severity of Intestinal Inflammation. , 2019, Gastroenterology.
[5] A. Talhouk,et al. Molecular Classification of Epithelial Ovarian Cancer Based on Methylation Profiling: Evidence for Survival Heterogeneity , 2019, Clinical Cancer Research.
[6] R. Satija,et al. Integrative single-cell analysis , 2019, Nature Reviews Genetics.
[7] M. Esteller,et al. Clinical epigenetics: seizing opportunities for translation , 2018, Nature Reviews Genetics.
[8] J. Gisbert,et al. Genetic variation analysis in a follow‐up study of gastric cancer precursor lesions confirms the association of MUC2 variants with the evolution of the lesions and identifies a significant association with NFKB1 and CD14 , 2018, International journal of cancer.
[9] E. Guinó,et al. New Methylation Biomarker Panel for Early Diagnosis of Dysplasia or Cancer in High-Risk Inflammatory Bowel Disease Patients. , 2018, Inflammatory bowel diseases.
[10] Herbert C. Wolfsen,et al. Highly Discriminant Methylated DNA Markers for the Non‐endoscopic Detection of Barrett's Esophagus , 2018, The American Journal of Gastroenterology.
[11] H. Yoon,et al. Reversibility of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication ‐ a prospective study for up to 10 years , 2018, Alimentary pharmacology & therapeutics.
[12] M. Teh,et al. Genomic and Epigenomic Profiling of High-Risk Intestinal Metaplasia Reveals Molecular Determinants of Progression to Gastric Cancer. , 2018, Cancer cell.
[13] L. Murray,et al. Adenocarcinoma risk in gastric atrophy and intestinal metaplasia: a systematic review , 2017, BMC Gastroenterology.
[14] P. Rosenstiel,et al. DNA Methylation and Transcription Patterns in Intestinal Epithelial Cells From Pediatric Patients With Inflammatory Bowel Diseases Differentiate Disease Subtypes and Associate With Outcome , 2017, Gastroenterology.
[15] D. Morgan,et al. Dynamics of Helicobacter pylori infection as a determinant of progression of gastric precancerous lesions: 16-year follow-up of an eradication trial , 2017, Gut.
[16] Hanze Wang,et al. Methylation-Sensitive Melt Curve Analysis of the Reprimo Gene Methylation in Gastric Cancer , 2016, PloS one.
[17] Emanuel J. V. Gonçalves,et al. A Landscape of Pharmacogenomic Interactions in Cancer , 2016, Cell.
[18] J. Gisbert,et al. Incomplete type of intestinal metaplasia has the highest risk to progress to gastric cancer: results of the Spanish follow‐up multicenter study , 2016, Journal of gastroenterology and hepatology.
[19] A. Califano,et al. High-definition CpG methylation of novel genes in gastric carcinogenesis identified by next-generation sequencing , 2016, Modern Pathology.
[20] A. Corvalán,et al. Helicobacter pylori-induced inflammation and epigenetic changes during gastric carcinogenesis. , 2015, World journal of gastroenterology.
[21] M. Westerhoff,et al. Methylated B3GAT2 and ZNF793 Are Potential Detection Biomarkers for Barrett's Esophagus , 2015, Cancer Epidemiology, Biomarkers & Prevention.
[22] P. Malfertheiner,et al. Somatic DNA Hypomethylation in H. pylori-Associated High-Risk Gastritis and Gastric Cancer: Enhanced Somatic Hypomethylation Associates with Advanced Stage Cancer , 2015, Clinical and Translational Gastroenterology.
[23] C. Mathers,et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.
[24] Rafael A. Irizarry,et al. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays , 2014, Bioinform..
[25] Lawrence C. LaPointe,et al. A panel of genes methylated with high frequency in colorectal cancer , 2014, BMC Cancer.
[26] J. Gisbert,et al. Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence , 2013, International journal of cancer.
[27] L. Bravo,et al. Virulence of infecting Helicobacter pyloristrains and intensity of mononuclear cell infiltration are associated with levels of DNA hypermethylation in gastric mucosae , 2013, Epigenetics.
[28] T. Chen,et al. The benefit of mass eradication of Helicobacter pylori infection: a community-based study of gastric cancer prevention , 2012, Gut.
[29] Guangchuang Yu,et al. clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.
[30] M. Piazuelo,et al. The gastric precancerous cascade , 2012, Journal of digestive diseases.
[31] L. Bravo,et al. Promoter DNA hypermethylation in gastric biopsies from subjects at high and low risk for gastric cancer , 2010, International journal of cancer.
[32] Ying-qiang Shi,et al. The role of surgery in the treatment of gastric cancer , 2010, Journal of surgical oncology.
[33] Nayoung Kim,et al. Comparison of CpG island hypermethylation and repetitive DNA hypomethylation in premalignant stages of gastric cancer, stratified for Helicobacter pylori infection , 2009, The Journal of pathology.
[34] Pan Du,et al. lumi: a pipeline for processing Illumina microarray , 2008, Bioinform..
[35] Jean YH Yang,et al. Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.
[36] S. Leung,et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. , 2004, JAMA.
[37] P. Laurén,et al. THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. , 1965, Acta pathologica et microbiologica Scandinavica.
[38] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[39] R. P. Blankfield,et al. Helicobacter pylori infection and the development of gastric cancer. , 2001, The New England journal of medicine.